David J Farrell
Overview
Explore the profile of David J Farrell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
173
Citations
3357
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hill T, Farrell D
Gerontol Geriatr Med
. 2022 Feb;
8:23337214221079176.
PMID: 35224140
Although there is agreement that COVID-19 has had devastating impacts in long-term care facilities (LTCFs), estimates of cases and deaths have varied widely with little attention to the causes of...
2.
Hill T, Farrell D
Gerontol Geriatr Med
. 2022 Jan;
8:23337214211073419.
PMID: 35071695
Throughout the pandemic, public health and long-term care professionals in our urban California county have linked local and state COVID-19 data and performed observational exploratory analyses of the impacts among...
3.
Farrell D, Mendes R, Bensaci M
Diagn Microbiol Infect Dis
. 2018 Oct;
93(1):85-88.
PMID: 30314652
Staphylococcus lugdunensis and Staphylococcus haemolyticus are unique among CoNS in that the former often causes aggressive disease, while the latter consistently exhibits high rates of multidrug resistance. We evaluated the...
4.
Marchand-Austin A, Tsang R, Guthrie J, Ma J, Lim G, Crowcroft N, et al.
J Clin Microbiol
. 2017 Feb;
55(5):1446-1453.
PMID: 28228490
is a Gram-negative bacterium that causes respiratory infections in humans. Ongoing molecular surveillance of acellular vaccine (aP) antigens is critical for understanding the interaction between evolutionary pressures, disease pathogenesis, and...
5.
Mendes R, Castanheira M, Farrell D, Flamm R, Sader H, Jones R
J Glob Antimicrob Resist
. 2016 Dec;
8:28-32.
PMID: 27939809
The aim of this study was to evaluate the prevalence of resistance to erythromycin alone (M) and to erythromycin and clindamycin (cMLS) as well as multidrug resistance (MDR) phenotypes (resistance...
6.
Sader H, Farrell D, Flamm R, Jones R
J Glob Antimicrob Resist
. 2016 Nov;
3(3):161-165.
PMID: 27873705
This study evaluated daptomycin activity trends among meticillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant enterococci (VRE) over a 5-year period (2009-2013). Consecutive, unique patient isolates of clinical significance were collected in...
7.
Mendes R, Sader H, Flamm R, Farrell D, Jones R
J Glob Antimicrob Resist
. 2016 Nov;
3(1):36-39.
PMID: 27873648
The broth microdilution method for telavancin susceptibility testing was revised and now utilises DMSO as solvent for stock solution preparation and diluent for stock solution dilution, following CLSI guidelines for...
8.
Mendes R, Castanheira M, Farrell D, Flamm R, Sader H, Jones R
J Antimicrob Chemother
. 2016 Sep;
71(12):3453-3458.
PMID: 27609052
Objectives: The objective of this study was to evaluate the prevalence and in vitro susceptibility of enterococci and VRE among bloodstream infections in European and US hospitals over time. Methods:...
9.
Flamm R, Rhomberg P, Huband M, Farrell D
Antimicrob Agents Chemother
. 2016 Jul;
60(10):6381-5.
PMID: 27458220
Delafloxacin, an investigational anionic fluoroquinolone, is active against a broad range of Gram-positive and Gram-negative bacteria. In this study, 200 Streptococcus pneumoniae (plus 30 levofloxacin-resistant isolates), 200 Haemophilus influenzae, and...
10.
Pfaller M, Flamm R, Jones R, Farrell D, Mendes R
Antimicrob Agents Chemother
. 2016 Jun;
60(9):5393-9.
PMID: 27353270
Tedizolid and linezolid in vitro activities against 3,032 Gram-positive pathogens collected in Asia-Pacific, Eastern European, and Latin American medical centers during 2014 were assessed. The isolates were tested for susceptibility...